Airway pharmacology Flashcards

1
Q

Bronchodilator drugs

A
  • Used to reverse inflammation of airways
  • Bronchodilator drugs act by binding to a specific receptor or enzyme expressed by the ASM cell and inducing an intracellular change which interrupts the contractile process (thereby causing relaxation).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

β2 agonists mechanism of action

A
  • Activation of β2 adrenergic receptors present in membrane of ASM cells
  • Includes a signalling cascade that increase production of cAMP and activation of PKA which reduces Ca2+ mobilisation, inducing relaxation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Examples of Short acting β 2 agonists

A

SALBUTAMOL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Examples of long acting β 2 agonists

A

SALMETEROL

FORMOTEROL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When is short acting β2 agonists used for

A

Administered when required as reliever therapy

Metered dose inhaler

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are long acting β2 agonists used for

A

Used as an add on preventer treatment, in combination with inhaled CORTICOSTEROIDS
In metered dose inhalers, with twice daily, continual dosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Long acting muscarinic receptor antagonists

A

A second class of bronchodilator drug e.g. TIOTROPIUM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mechanism of action for long acting muscarinic receptor antagonists

A
  • Blocking acetylcholine receptors present on ASM cells

- Reduces the level of contraction in situations where ACh plays a role in inducing ASM contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When are long acting muscarinic receptor antagonists used

A
  • Used to treat chronic bronchitis in COPD patients, and as an add on, preventer therapy in asthma
  • Dosed on a dailym continual basis via metered dose inhalers
  • may also provide benefit in patients with obstructive airway diseases by reducing mucus secretion and inhibiting cough
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Corticosteroids

A

most effective and widely used drug for reducing allergic inflammation in asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Examples of corticosteroids

A

fluticasone
beclometasone
budesonide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mechanism of action for corticosteroids

A
  • Achieve their anti-inflammatory effect by binding to glucocorticoid receptors present within the cytosol of immune and structural cells
  • The bound drug receptor complex migrates to nucleus of the cell where it binds to DNA. Modulating transcription, translation and protein expression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are leukotrienes

A

Are a group of pro-inflammatory lipid mediators that are implicated in the asthmatic immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What releases leukotrienes

A

Mast cells and eosinophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do leukotrienes do

A

Induce further inflammation and airway pathology via receptor mediated actions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mechanism of action for leukotriene receptor antagonists

A

When blocking leukotriene receptors it reduces the level of inflammation.

17
Q

Example of leukotriene receptor antagonists

A

Montelukast - administered orally and used as an add-on preventer therapy with continual dosing

18
Q

Biologics

A

refer to drugs consisting of complex biomolecules

19
Q

Mechanism of action for biologics

A

Used in asthma therapy to block or inhibit specific pro-inflammatory protein involved in the inflammatory cascade

20
Q

All drugs are capable of inducing adverse effects due to either

A
  • Interacting excessively with their primary target

- Interacting with targets expressed in other tissues

21
Q

Several other drugs used in respiratory disease are delivered by other routes of administration. Used when:

A
  • Drug intended to have a systemic effect
  • The drug has a narrow therapeutic window, and so a consistent dose must reach the systemic circulation
  • It is not possible to formulate the drug as an inhaler due to the physical/chemical properties of the drug
22
Q

Reasons for adverse effects β2 agonist

A
  • Although majority of β receptors present within the heart of β1 sub-type there is still a significant number of β2 receptors
  • At high doses β2 agonist will interact with β1 receptors
  • β2 receptors are found on skeletal muscle, posing risk of tremor. And hypertrophy and muscle growth
23
Q

Adverse effects associated with corticosteroids

A

Growth retardation
Skin ulcers
Osteoporosis - effects of glucocorticoids on bone metabolism
Hypercortisolism - increased expoure to glucocorticoids
Candidiasis

24
Q

Adverse effects of β2 adrenergic receptor agonists

A

Tremor - β2 receptors expressed on skeletal muscle
Tachycardia - β1 receptors expressed by cells of SA node in heart
Palpitations - β1 receptors expressed by myocardium